Medtronic and Johnson & Johnson are two of the most powerful public companies in healthcare, according to Forbes.
Forbes determined the most powerful companies using a composite score of revenue, profit, assets and market value. Forbes analyzed companies' financial results for the 12 months ending on April 18, 2019.
Ten devicemakers that made the "2019 Forbes Global 2000" list:
Johnson & Johnson (No. 37)
Sales: $81.6 billion
Profits: $14.7 billion
Assets: $153 billion
Market value: $366.2 billion
Medtronic (No. 150)
Sales: $30.6 billion
Profits: $4.9 billion
Assets: $88.7 billion
Market value: $113 billion
Becton Dickinson (No. 355)
Sales: $17.1 billion
Profits: $1 billion
Assets: $52.9 billion
Market value: $61.3 billion
Stryker (No. 366)
Sales: $13.6 billion
Profits: $3.6 billion
Assets: $27.2 billion
Market value: $67.3 billion
Boston Scientific (No. 557)
Sales: $9.8 billion
Profits: $1.7 billion
Assets: $21 billion
Market value: $48.8 billion
Intuitive Surgical (No. 1,013)
Sales: $3.7 billion
Profits: $1.1 billion
Assets: $7.8 billion
Market value: $60.9 billion
Zimmer Biomet (No. 1,027)
Sales: $7.9 billion
Profits: -$379 million
Assets: $24.1 billion
Market value: $24.6 billion
Henry Schein (No. 1,248)
Sales: $13.2 billion
Profits: $536 million
Assets: $8.5 billion
Market value: $9.2 billion
DaVita (No. 1,313)
Sales: $11.4 billion
Profits: $159 million
Assets: $19.3 billion
Market value: $8.7 billion
Smith & Nephew (No. 1,377)
Sales: $4.9 billion
Profits: $666 million
Assets: $8.1 billion
Market value: $16.4 billion